日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report

一例携带EML4-ALK融合基因的肺鳞状细胞癌患者对阿来替尼治疗短期有效但病情迅速进展:病例报告

Li, Shengshu; Du, Xiaosong; Zhang, Xinxin; Ma, Haixia; Yang, Yanli; Li, Yuan; Wei, Qin; Chen, Yan; Li, Hongwei; Bu, Peng; Liu, Dujuan; Han, Songyan; Chen, Deyi

Advances in the mechanisms, imaging characteristics and management strategies for immune checkpoint inhibitor-related pneumonitis

免疫检查点抑制剂相关性肺炎的机制、影像学特征和治疗策略方面的进展

Li, Shengshu; Geng, Ziying; Hong, Shuang; Zhang, Jianxin; Yang, Yanli; Wei, Qin; Zhang, Xinxin; Zhuang, Xiaofei; Huo, Rujie; Han, Songyan; Wang, Jie

Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches

复发性小细胞肺癌免疫化疗的真实世界分析:二线治疗的机遇

Guo, Yanrong; Han, Songyan; Guo, Qinxiang; Zhai, Jinfang; Ren, Xiaohui; Li, Shengshu; Duan, Jianchun

Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

甲基转移酶样 3 通过加速 m6A 甲基化介导的初级 miR-663 加工和抑制 SOCS6 表达来促进肺癌进展

Li Shengshu, Lu Xiaoxin, Zheng Dongyang, Chen Weizong, Li Yuzhu, Li Fang

Antifatigue Effects of Antrodia cinnamomea Cultured Mycelium via Modulation of Oxidative Stress Signaling in a Mouse Model

牛樟芝培养菌丝体通过调节小鼠模型中的氧化应激信号发挥抗疲劳作用

Yange Liu, Lanzhou Li, Shengshu An, Yuanzhu Zhang, Shiwei Feng, Lu Zhao, Lirong Teng, Di Wang